Company Overview
Snapshot
Founded in May 2021, Sentient Synthetics operates with 1-10 employees. Co-founder Prof. Yonatan (Yoni) Savir leads the company, which has secured funding across one round. In September 2021, the company was selected for the Starfinder Lab program by aMoon fund and Roche Diagnostics.
Business overview
Sentient Synthetics is an AI-based digital pathology company that develops solutions to overcome data limitations in computational pathology. The company leverages machine learning to create validated, affordable, and thoroughly labeled synthetic pathology datasets. These datasets are designed to enable faster and more accurate training and validation for AI algorithms used by medical research centers, digital health companies, pharmaceutical firms, and diagnostics providers, covering all cancer tissue types, including rarer forms. Sentient Synthetics operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics, targeting enterprise and professional services, as well as the broader healthcare and life sciences industries.
Strategic signal
In September 2021, Sentient Synthetics was selected by aMoon fund and Roche Diagnostics for their Starfinder Lab program. This partnership provides Sentient Synthetics with $250,000 in financing and access to medical databases and resources, validating the company's approach to digital pathology and its potential to address critical challenges in healthcare through AI systems and synthetic data.
Log in to access full profile ›Company Intelligence Q&A
- When was Sentient Synthetics founded?
- Sentient Synthetics was founded in May 2021.
- What significant program did Sentient Synthetics join in September 2021?
- In September 2021, Sentient Synthetics was selected for the Starfinder Lab program by aMoon fund and Roche Diagnostics. This program provided $250,000 in financing and access to medical databases and resources.
- Who is a co-founder of Sentient Synthetics?
- Prof. Yonatan (Yoni) Savir is a co-founder and CSO of Sentient Synthetics.
- What is the primary focus of Sentient Synthetics' technology?
- Sentient Synthetics focuses on leveraging machine learning to create synthetic pathology datasets. These datasets aim to overcome existing data limitations in computational pathology for training and validating AI algorithms.
- What is the company's primary sector?
- Sentient Synthetics' primary sector is Health Tech & Life Sciences, specifically within Digital Healthcare and Digital Medical Diagnostics.